Markets in Seoul, Hong Kong, and Tokyo are all pointing upward. Learn why buying dips in the KOSPI, Hang Seng and Nikkei 225 ...

DelveInsight's Oncolytic Virus Competitive Landscape 2026 report provides comprehensive global coverage of pipeline oncolytic ...

AbbVie (NYSE:ABBV) has agreed to acquire Capstan Therapeutics to expand its work in in vivo CAR-T cell therapy. The company ...

Enterprises are keen to invest in network automation, SASE, and Wi-Fi 7, and they need networking pros with skills that span ...

Jen Lamppa, VP of Commercial Strategy at Inovalon, says that RWD will be held to the same scrutiny as trial data if used in ...

With the expanded indication, Efmody is now indicated for both adrenal insufficiency and congenital adrenal hyperplasia in ...

The FDA and EMA have aligned on ten guiding principles for the responsible use of artificial intelligence across the drug development lifecycle, establishing a shared framework to support innovation, ...

Pharming Group (NASDAQ:PHAR) outlined its 2026 financial guidance and provided updates on its commercial portfolio and late-stage pipeline during its 2026 Investor Day, emphasizing continued revenue ...

In Dutch supermarkets, for example, over-the-counter ibuprofen can come in neon pink. However, according to European ...

Despite deteriorating earnings revisions and weak growth, Accenture's profitability remains outstanding. Check out why ACN ...

ICH E6 (R3) introduces a dedicated section on data governance, reflecting the increasing complexity of data sources and ...

The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders, such as Candel Therapeutic ...